Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity

Biochemical Pharmacology

Volumn 55, Issue 9, 1998, Pages 1385-1390

  Yamashiro, Takashi ^a   Watanabe, Naoko ^a   Yokoyama, Kazunari K ^b   Koga, Chie ^b   Tsuruo, Takashi ^c   Kobayashi, Yoshiro ^a  

^a Faculty of Science   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antisense oligonucleotide; Cytotoxicity; NK cells; P glycoprotein

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GLYCOPROTEIN P; IMMUNOGLOBULIN F(AB) FRAGMENT; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE; CELL SURVIVAL; CYTOTOXICITY, IMMUNOLOGIC; DIHYDROPYRIDINES; DRUG RESISTANCE, MULTIPLE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, LYMPHOBLASTIC; NICARDIPINE; OLIGONUCLEOTIDES, ANTISENSE; P-GLYCOPROTEIN; PYRAZOLES; RNA, MESSENGER; THYMOMA; THYMUS NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032499421     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00652-7     Document Type: Article

References (26)

1. Gottesman MM, Pastan I. Resistance to multiple chemotherapeutic agents in human cancer cells. Trends Pharmacol Sci. 9:1988;54-58.
2. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product, P-glycoprotein, in normal human tissues. Proc Natl Acad Sci USA. 84:1987;7735-7738.
3. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood. 80:1992;2729-2734.
4. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 80:1992;2735-2739.
5. Tatsuta T, Naito M, Oh-hara T, Sugawara I, Tsuruo T. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem. 267:1992;20383-20391.
6. O'Brien JA, Walters RJ, Sepulveda FV. Regulatory volume decrease in small intestine crypts is inhibited by potassium and chloride channel blockers. Biochim Biophys Acta. 1070:1991;501-504.
7. Tominaga M, Tominaga T, Miwa A, Okada Y. Volume-sensitive chloride channel activity does not depend on endogenous P-glycoprotein. J Biol Chem. 270:1995;27887-27893.
8. Kobayashi Y, Yamashiro T, Nagatake H, Yamamoto T, Watanabe N, Tanaka H, Shigenobu K, Tsuruo T. Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52. Biochemical Pharmacol. 48:1994;1641-1646.
9. Chong AS-F, Markham PN, Gebel HM, Bines SD, Coon JS. Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother. 36:1993;133-139.
10. Gupta S, Kim CH, Tsuruo T, Gollapudi S. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells A role in cytotoxic effector function . J Clin Immunol. 12:1992;451-458.
11. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol. 149:1992;1115-1123.
12. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, Takigawa M, Sasaki M, Minato N, Tsudo M, Uchiyama T, Maeda M. TCGF (IL-2)-receptor inducing factor(s). I Regulation of IL-2 receptor on a natural killer-like cell line (YT cell) . J Immunol. 134:1985;1623-1630.
13. Yamamoto T, Iwasaki T, Watanabe N, Oshimi K, Naito M, Tsuruo T, Kobayashi Y. Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. Blood. 81:1993;1342-1346.
14. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 66:1991;85-94.
15. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA. 87:1990;7160-7164.
16. Walsh CM, Glass AA, Chiu V, Clark WR. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J Immunol. 153:1994;2506-2514.
17. Gros P, Croop J, Houseman D. Mammalian multidrug resistance gene Complete cDNA sequence indicates strong homology to bacterial transport proteins . Cell. 47:1986;371-380.
18. Rivoltini L, Colombo MP, Supino R, Ballinari D, Tsuruo T, Parmiani G. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line. Int J Cancer. 46:1990;727-732.
19. Hamada H, Tsuruo T. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. Proc Natl Acad Sci USA. 83:1986;7785-7789.
20. Klopman G, Srivastava S, Kolossvary I, Epand RF, Ahmed N, Epand RM. Structure-activity study and design of multidrug-resistant reversal compounds by a computer automated structure evaluation methodology. Cancer Res. 52:1992;4121-4129.
21. Shinoda H, Inaba M, Tsuruo T. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52. Cancer Res. 49:1989;1722-1726.
22. Masuda T, Iwama T, Yamashita T, Sakai T, Hibi M, Tanaka S, Shigenobu K, Kasuya Y. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta. Arch Int Pharmacodyn Ther. 312:1991;86-103.
23. Doherty PC. Cell-mediated cytotoxicity. Cell. 75:1993;607-612.
24. Ruetz S, Gros P. Functional expression of P-glycoprotein in secretory vesicles. J Biol Chem. 269:1994;12277-12284.
25. --dependent intracellular pH regulation in murine MDR 1 transfectants and potential implications. Biochemistry. 33:1994;11008-11015.
26. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceti RJ, Kramer R, Guidotti G, Cantiello HF. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA. 90:1993;312-316.